Cargando…
Integrative In Silico Investigation Reveals the Host-Virus Interactions in Repurposed Drugs Against SARS-CoV-2
The ongoing COVID-19 outbreak have posed a significant threat to public health worldwide. Recently Toll-like receptor (TLR) has been proposed to be the drug target of SARS-CoV-2 treatment, the specificity and efficacy of such treatments remain unknown. In the present study we performed the investiga...
Autores principales: | Yu, Wenhui, Bai, Yuxin, Raha, Arjun, Su, Zhi, Geng, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580895/ https://www.ncbi.nlm.nih.gov/pubmed/36303774 http://dx.doi.org/10.3389/fbinf.2021.763540 |
Ejemplares similares
-
Repurposing FDA-approved drugs as FXR agonists: a structure based in silico pharmacological study
por: Jose, Sandra, et al.
Publicado: (2023) -
Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach
por: Loganathan, Tamizhini, et al.
Publicado: (2020) -
In silico predictions of protein interactions between Zika virus and human host
por: Pitta, João Luiz de Lemos Padilha, et al.
Publicado: (2021) -
Orthogonal analysis of variants in APOE gene using in-silico approaches reveals novel disrupting variants
por: Li, Chang, et al.
Publicado: (2023) -
Chikungunya virus time course infection of human macrophages reveals intracellular signaling pathways relevant to repurposed therapeutics
por: Gray, Madison, et al.
Publicado: (2022)